Endocrinopathies in transfusion-associated iron overload

被引:22
|
作者
Kim, Mee Kyoung [1 ]
Lee, Jong Wook [1 ]
Baek, Ki Hyun [1 ]
Song, Ki Ho [1 ]
Kwon, Hyuk Sang [1 ]
Oh, Ki Won [2 ]
Jang, Eun Hee [1 ]
Kang, Moo Il [1 ]
Lee, Kwang Woo [1 ]
机构
[1] Catholic Univ Korea, Dept Internal Med, Seoul 150713, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Internal Med, Seoul, South Korea
关键词
HEREDITARY HEMOCHROMATOSIS; ENDOCRINE ABNORMALITIES; INSULIN-RESISTANCE; DIABETES-MELLITUS; CHELATION-THERAPY; APLASTIC-ANEMIA; GLUCOSE; PREVALENCE; DIAGNOSIS; SECONDARY;
D O I
10.1111/j.1365-2265.2012.04495.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Transfusional iron overload primarily results in reticuloendothelial iron accumulation, which is considered to be less harmful than parenchymal iron accumulation. However, systematic and comprehensive data on endocrine function in transfusion-associated haemochromatosis are limited. Methods We examined 25 aplastic anaemia patients (11 men and 14 women) diagnosed with transfusion-associated haemochromatosis at a single institution. Pituitary function was determined with a combined pituitary function test. On a different day, a 75-g oral glucose tolerance test was performed. The bone mineral density (BMD) of the lumbar spine and total hip was assessed with dual-energy X-ray absorptiometry. Results Twenty-two (88%) of these 25 patients had at least one endocrine abnormality, and 12 had more than one abnormality. The most common pituitary hormonal deficiency involved the pituitarygonadal axis; 54% of the total subjects had hypogonadotropic hypogonadism. Two patients had an insufficient cortisol response to corticotrophin-releasing hormone stimulation. No patient had a deficiency of growth hormone or thyroid-stimulating hormone. Twelve (48%) had diabetes mellitus, and these patients tended to have higher concentrations of ferritin, alanine aminotransferase and ?-glutamyl transferase. Osteoporosis (T-score <-2.5 SD) was observed in 48% of patients. The reduction in BMD was more pronounced in the lumbar spine than in the total hip. The patients with osteoporosis were accompanied by hypogonadism, which predominantly affected the trabecular bone. Conclusions Our observations suggest that endocrinopathies are common in transfusion-associated haemochromatosis.
引用
收藏
页码:271 / 277
页数:7
相关论文
共 50 条
  • [41] Myocardial Iron Overload in Sickle Cell Disease: A Rare But Potentially Fatal Complication of Transfusion
    Junqueira Tavares, Alvaro Henrique
    Benites, Bruno Deltreggia
    Fertrin, Kleber Yotsumoto
    TRANSFUSION MEDICINE REVIEWS, 2019, 33 (03) : 170 - 175
  • [42] Association of Iron Overload and Oxidative Stress with Insulin Resistance in Transfusion-Dependent β-Thalassemia Major and β-Thalassemia/HbE Patients
    Tangvarasittichai, Surapon
    Pimanprom, Ampai
    Choowet, Anuchit
    Tangvarasittichai, Orathai
    CLINICAL LABORATORY, 2013, 59 (7-8) : 861 - 868
  • [43] Overview of endocrinopathies associated with β-thalassaemia major
    Perera, N. J.
    Lau, N. S.
    Mathews, S.
    Waite, C.
    Ho, P. J.
    Caterson, I. D.
    INTERNAL MEDICINE JOURNAL, 2010, 40 (10) : 689 - 696
  • [44] Fulminant Transfusion-Associated Hepatitis E Virus Infection Despite Screening, England, 2016-2020
    Harvala, Heli
    Reynolds, Claire
    Brailsford, Su
    Davison, Katy
    EMERGING INFECTIOUS DISEASES, 2022, 28 (09) : 1805 - 1813
  • [45] Iron overload
    Siah, CW
    Trinder, D
    Olynyk, JK
    CLINICA CHIMICA ACTA, 2005, 358 (1-2) : 24 - 36
  • [46] Understanding the Intricacies of Iron Overload Associated with β-Thalassemia: A Comprehensive Review
    Basu, Subhangi
    Rahaman, Motiur
    Dolai, Tuphan Kanti
    Shukla, Praphulla Chandra
    Chakravorty, Nishant
    THALASSEMIA REPORTS, 2023, 13 (03) : 179 - 194
  • [47] Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements
    Remacha, Angel F.
    Arrizabalaga, Beatriz
    Del Canizo, Consuelo
    Sanz, Guillermo
    Villegas, Ana
    ANNALS OF HEMATOLOGY, 2010, 89 (02) : 147 - 154
  • [48] Deferasirox: an orphan drug for chronic iron overload in non-transfusion dependent thalassemia syndromes
    Halawi, Racha
    Motta, Irene
    Taher, Ali
    Cappellini, Maria Domenica
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (06): : 677 - 686
  • [49] Early Detection of Iron Overload Cardiomyopathy in Transfusion Dependent Thalassemia Patients in Sulaimaniyah City, Iraq
    Ahmed, Rana Adnan
    Salih, Aso Faeq
    Omer, Shirwan Hamasalih
    Rahman, Heshu Sulaiman
    Rasool, Luqman Khalid
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2022, 18 : 259 - 271
  • [50] Approaches to Transfusion Therapy and Iron Overload in Patients with Sickle Cell Disease: Results of an International Survey
    Vichinsky, Elliott P.
    Ohene-Frempong, Kwaku
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2011, 28 (01) : 37 - 42